Protogenix
Founded 2020 · $250K raised
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- proto-genix.com
- Total Funding
- $250K
- Last Round
- $250K SeedDec 2025
- Rounds
- 1
About
Protogenix (formerly Forte Protein) is an early-stage biotechnology company developing a novel protein production platform. The company is focused on making protein manufacturing faster and more cost-effective. The website is currently in a coming-soon state, limiting available detail.
Summary
Protogenix is a Biotech company, founded in 2020. It has raised $250K in total across 1 round, most recently a $250K Seed round in Dec 2025. Investors include IndieBio, SOSV and New York Ventures.
Tech & App Stack
6 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Dec 2025
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...